HealthTech
NRG Therapeutics
NRG Therapeutics raises $67M Series B
$67M
Total Raised
Series B
Latest Round
2020
Founded
60+
Employees
Cambridge, UK
1 min read
Quick Facts
Latest Round Size
$67M
Latest Round Date
September 2025
NRG Therapeutics: Series B Funding Round
NRG Therapeutics has successfully raised $67M in Series B funding.
Company Overview
Developing treatments for ALS and neurodegenerative diseases
Funding Details
The Series B round was led by Multiple investors.
Company Information
- Headquarters: Cambridge, UK
- Founded: 2020
- Employees: 60+
- Category: HealthTech
Investment
NRG Therapeutics plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Multiple investors: Verified investor in Series B
Key Investors
Multiple investors
Lead Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
HealthTech
AccelerateStack Platform
AccelerateStack Platform raises $75M Series C at $226M valuation
AccelerateStack Platform secures $75M in Series C funding led by Intel Capital, reaching $226M valuation as it accelerates growth in the healthtech sector.
Michael Rodriguez
Oct 8, 2025
3 min read•$75M
HealthTech
DermaSensor
DermaSensor raises $16M Series B at $85M valuation
DermaSensor raises $16M in Series B at $85M valuation. AI-powered skin cancer screening device for early detection...
Editorial Team
Oct 6, 2025
1 min read•$16M
HealthTech
Devoted Health Partners
Devoted Health Partners Headquarters - Office Location & Address
Discover Devoted Health Partners's headquarters at 100 2nd Ave, Waltham, MA 02451. Medicare Advantage insurance. Learn about the office facilities and work environment.
Editorial Team
Oct 5, 2025
2 min read